Views

Woman in shadow looking through binoculars with the sun in the background

View Sep 8, 2026

Voices of Rare Disease: Perspectives Across the Community

View Aug 26, 2026

What’s Really Behind the Drop in the U.S. Consumer Price Index for Prescription Drugs?

View Aug 19, 2026

Harmonizing Pharmacovigilance and Pharmacoepidemiology: Lessons from Europe for Cohesive Medicines Safety Science

View Aug 19, 2026

Whole-Person Oncology: Making Multidisciplinary Care and Access the Standard

View Aug 17, 2026

Feasibility Assessment Comparing Suitability of Secondary Databases to Assess Safety of Amyloid-targeting Therapies in Brazil

View Aug 17, 2026

Feasibility Assessment Comparing Suitability of UK Databases CPRD-HES and Arcturis RWD Network for Safety Studies of Amyloid-targeting Therapies in Alzheimer’s Disease

View Aug 7, 2026

Volatility and Value: Rewriting the Playbook for Pharma Development and Commercialization

View Aug 5, 2026

European Academy of Neurology (EAN) 2026 Congress Insights

View Aug 4, 2026

Early Decisions Shape CNS Drug Success

View Aug 3, 2026

Beyond the Mainstream: Addressing Neglected Tumor Types

View Jul 24, 2026

Rare Disease Regulatory Strategy in 2026: Critical Priorities for Today’s Environment

View Jul 22, 2026

Playing Nicely with Friends: Portfolio Co-Positioning

Hot Air Balloon floats over windy river

View Jul 20, 2026

First & Best in Class Oncology Innovation

View Jul 17, 2026

EHA 2026 Congress Insights

View Jul 13, 2026

Good Messaging Isn’t Enough

View Jul 9, 2026

Detecting Patients with Chronic Kidney Disease Using General Practitioner Electronic Health Records and Electronic Phenotypes

1 2 3 … 24